| Authors: |
Patel MH; Hackensack Meridian School of Medicine, Nutley, NJ., Lodha R; Cleveland Clinic Lerner College of Medicine, Cleveland, OH., Millan B; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Blachman-Braun R; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Loebach L; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Pramod N; Cleveland Clinic Lerner College of Medicine, Cleveland, OH., Saini J; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Koller C; Department of Urology, Hackensack University Medical Center, Hackensack, NJ., Stecko H; Ohio State University College of Medicine, Columbus, OH., Gurram S; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Turkbey B; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Linehan WM; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Ball MW; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: mark.ball@nih.gov. |
